Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | plasmepsin VI | 0.0127 | 0.1638 | 0.4573 |
Toxoplasma gondii | aspartyl protease ASP3 | 0.0221 | 0.3583 | 1 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.0127 | 0.1638 | 0.5 |
Plasmodium vivax | aspartyl protease, putative | 0.0221 | 0.3583 | 1 |
Plasmodium falciparum | plasmepsin IX | 0.0221 | 0.3583 | 1 |
Plasmodium falciparum | plasmepsin I | 0.0127 | 0.1638 | 0.4573 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0127 | 0.1638 | 0.4573 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0127 | 0.1638 | 0.1638 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.0127 | 0.1638 | 0.4573 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.0127 | 0.1638 | 0.5 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.0127 | 0.1638 | 1 |
Onchocerca volvulus | 0.0049 | 0 | 0.5 | |
Brugia malayi | Pepsin A precursor | 0.0049 | 0 | 0.5 |
Brugia malayi | aspartic protease BmAsp-1, identical | 0.0049 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0127 | 0.1638 | 1 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0127 | 0.1638 | 0.4573 |
Plasmodium falciparum | plasmepsin II | 0.0127 | 0.1638 | 0.4573 |
Plasmodium falciparum | plasmepsin X | 0.0221 | 0.3583 | 1 |
Plasmodium falciparum | plasmepsin IV | 0.0127 | 0.1638 | 0.4573 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.0127 | 0.1638 | 0.5 |
Brugia malayi | hypothetical protein | 0.0049 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0049 | 0 | 0.5 |
Plasmodium vivax | aspartyl protease, putative | 0.0221 | 0.3583 | 1 |
Brugia malayi | Eukaryotic aspartyl protease family protein | 0.0049 | 0 | 0.5 |
Brugia malayi | aspartic protease BmAsp-2, identical | 0.0049 | 0 | 0.5 |
Onchocerca volvulus | 0.0049 | 0 | 0.5 | |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0529 | 1 | 1 |
Plasmodium vivax | plasmepsin IV, putative | 0.0127 | 0.1638 | 0.4573 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 66 uM | PUBCHEM_BIOASSAY: Dose-response secondary confirmation of microRNA-mediated mRNA deacetylation inhibitors by fluorescence polarization assay using Cy5 labeled peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | > 66 uM | PUBCHEM_BIOASSAY: Dose-response confirmation of microRNA-mediated mRNA deacetylation inhibitors by fluorescence polarization assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 0.2239 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.